![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM25 |
Gene summary for TMEM25 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM25 | Gene ID | 84866 |
Gene name | transmembrane protein 25 | |
Gene Alias | TMEM25 | |
Cytomap | 11q23.3 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | Q86YD3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84866 | TMEM25 | LZE4T | Human | Esophagus | ESCC | 2.32e-04 | 1.37e-01 | 0.0811 |
84866 | TMEM25 | LZE22T | Human | Esophagus | ESCC | 2.36e-07 | 6.38e-01 | 0.068 |
84866 | TMEM25 | LZE24T | Human | Esophagus | ESCC | 2.44e-11 | 3.13e-01 | 0.0596 |
84866 | TMEM25 | P2T-E | Human | Esophagus | ESCC | 7.77e-17 | 2.35e-01 | 0.1177 |
84866 | TMEM25 | P4T-E | Human | Esophagus | ESCC | 9.35e-18 | 4.19e-01 | 0.1323 |
84866 | TMEM25 | P5T-E | Human | Esophagus | ESCC | 4.68e-11 | 1.77e-01 | 0.1327 |
84866 | TMEM25 | P8T-E | Human | Esophagus | ESCC | 1.55e-10 | 2.36e-01 | 0.0889 |
84866 | TMEM25 | P9T-E | Human | Esophagus | ESCC | 1.27e-07 | 1.27e-01 | 0.1131 |
84866 | TMEM25 | P10T-E | Human | Esophagus | ESCC | 2.46e-17 | 3.60e-01 | 0.116 |
84866 | TMEM25 | P11T-E | Human | Esophagus | ESCC | 1.87e-15 | 6.49e-01 | 0.1426 |
84866 | TMEM25 | P12T-E | Human | Esophagus | ESCC | 5.62e-30 | 4.52e-01 | 0.1122 |
84866 | TMEM25 | P15T-E | Human | Esophagus | ESCC | 3.44e-04 | 1.22e-01 | 0.1149 |
84866 | TMEM25 | P16T-E | Human | Esophagus | ESCC | 3.65e-28 | 5.04e-01 | 0.1153 |
84866 | TMEM25 | P17T-E | Human | Esophagus | ESCC | 1.47e-03 | 2.64e-01 | 0.1278 |
84866 | TMEM25 | P21T-E | Human | Esophagus | ESCC | 1.47e-34 | 6.55e-01 | 0.1617 |
84866 | TMEM25 | P22T-E | Human | Esophagus | ESCC | 1.14e-14 | 2.86e-01 | 0.1236 |
84866 | TMEM25 | P24T-E | Human | Esophagus | ESCC | 2.17e-08 | 1.43e-01 | 0.1287 |
84866 | TMEM25 | P26T-E | Human | Esophagus | ESCC | 8.63e-21 | 4.25e-01 | 0.1276 |
84866 | TMEM25 | P27T-E | Human | Esophagus | ESCC | 1.78e-17 | 2.56e-01 | 0.1055 |
84866 | TMEM25 | P28T-E | Human | Esophagus | ESCC | 1.49e-10 | 1.16e-01 | 0.1149 |
Page: 1 2 3 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1901214110 | Oral cavity | LP | regulation of neuron death | 115/4623 | 319/18723 | 3.39e-06 | 7.19e-05 | 115 |
GO:190589812 | Oral cavity | LP | positive regulation of response to endoplasmic reticulum stress | 20/4623 | 35/18723 | 4.16e-05 | 6.05e-04 | 20 |
GO:190429411 | Oral cavity | LP | positive regulation of ERAD pathway | 9/4623 | 14/18723 | 1.95e-03 | 1.45e-02 | 9 |
GO:190121515 | Oral cavity | LP | negative regulation of neuron death | 69/4623 | 208/18723 | 3.50e-03 | 2.34e-02 | 69 |
GO:007008511 | Oral cavity | LP | glycosylation | 77/4623 | 240/18723 | 5.60e-03 | 3.38e-02 | 77 |
GO:000648611 | Oral cavity | LP | protein glycosylation | 73/4623 | 226/18723 | 5.72e-03 | 3.44e-02 | 73 |
GO:004341311 | Oral cavity | LP | macromolecule glycosylation | 73/4623 | 226/18723 | 5.72e-03 | 3.44e-02 | 73 |
GO:000989633 | Oral cavity | NEOLP | positive regulation of catabolic process | 111/2005 | 492/18723 | 1.19e-14 | 4.72e-12 | 111 |
GO:004217634 | Oral cavity | NEOLP | regulation of protein catabolic process | 92/2005 | 391/18723 | 1.77e-13 | 5.27e-11 | 92 |
GO:003133133 | Oral cavity | NEOLP | positive regulation of cellular catabolic process | 97/2005 | 427/18723 | 3.77e-13 | 1.07e-10 | 97 |
GO:001049831 | Oral cavity | NEOLP | proteasomal protein catabolic process | 103/2005 | 490/18723 | 1.08e-11 | 1.65e-09 | 103 |
GO:190336234 | Oral cavity | NEOLP | regulation of cellular protein catabolic process | 64/2005 | 255/18723 | 4.83e-11 | 6.11e-09 | 64 |
GO:004573233 | Oral cavity | NEOLP | positive regulation of protein catabolic process | 58/2005 | 231/18723 | 3.80e-10 | 3.18e-08 | 58 |
GO:004586233 | Oral cavity | NEOLP | positive regulation of proteolysis | 80/2005 | 372/18723 | 7.28e-10 | 5.54e-08 | 80 |
GO:190305034 | Oral cavity | NEOLP | regulation of proteolysis involved in cellular protein catabolic process | 54/2005 | 221/18723 | 4.32e-09 | 2.49e-07 | 54 |
GO:190336433 | Oral cavity | NEOLP | positive regulation of cellular protein catabolic process | 41/2005 | 155/18723 | 2.87e-08 | 1.22e-06 | 41 |
GO:006113632 | Oral cavity | NEOLP | regulation of proteasomal protein catabolic process | 46/2005 | 187/18723 | 4.76e-08 | 1.95e-06 | 46 |
GO:003497632 | Oral cavity | NEOLP | response to endoplasmic reticulum stress | 56/2005 | 256/18723 | 1.39e-07 | 4.84e-06 | 56 |
GO:190180031 | Oral cavity | NEOLP | positive regulation of proteasomal protein catabolic process | 29/2005 | 114/18723 | 6.80e-06 | 1.36e-04 | 29 |
GO:190305232 | Oral cavity | NEOLP | positive regulation of proteolysis involved in cellular protein catabolic process | 32/2005 | 133/18723 | 8.26e-06 | 1.60e-04 | 32 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM25 | deletion | Frame_Shift_Del | novel | c.575delA | p.Asn192ThrfsTer85 | p.N192Tfs*85 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | |||
TMEM25 | SNV | Missense_Mutation | novel | c.758G>A | p.Ser253Asn | p.S253N | protein_coding | tolerated(0.29) | benign(0.062) | TCGA-C5-A8XK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD | |
TMEM25 | SNV | Missense_Mutation | rs782188288 | c.145G>A | p.Ala49Thr | p.A49T | protein_coding | tolerated(0.54) | benign(0.207) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM25 | SNV | Missense_Mutation | c.1033N>T | p.Leu345Phe | p.L345F | protein_coding | tolerated_low_confidence(0.07) | benign(0.015) | TCGA-FU-A3EO-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
TMEM25 | SNV | Missense_Mutation | novel | c.97N>A | p.Asp33Asn | p.D33N | protein_coding | tolerated(0.2) | probably_damaging(0.998) | TCGA-IR-A3LK-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | PD | |
TMEM25 | SNV | Missense_Mutation | novel | c.224G>A | p.Ser75Asn | p.S75N | protein_coding | tolerated(0.51) | benign(0.007) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
TMEM25 | SNV | Missense_Mutation | rs377765778 | c.599N>A | p.Arg200His | p.R200H | protein_coding | tolerated(0.3) | benign(0.003) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM25 | SNV | Missense_Mutation | rs75184401 | c.458C>T | p.Ala153Val | p.A153V | protein_coding | tolerated(0.5) | benign(0.213) | TCGA-AG-3883-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
TMEM25 | deletion | Frame_Shift_Del | c.166delN | p.Pro58LeufsTer23 | p.P58Lfs*23 | protein_coding | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | ||||
TMEM25 | deletion | Frame_Shift_Del | c.166delN | p.Pro58LeufsTer23 | p.P58Lfs*23 | protein_coding | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |